MedPath

Role of haritaki arka in neonatal jaundice

Phase 3
Conditions
Health Condition 1: K77- Liver disorders in diseases classified elsewhere
Registration Number
CTRI/2023/06/053537
Lead Sponsor
Sri Dharmasthala Manjunateshwara College of Ayurved and Hospital, Hassan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.All new born babies extracted through LSCS

2.Neonates whose parents are willing to give written consent for the trial

Exclusion Criteria

1. New born baby with birth asphyxia

2. New born baby congenital anomalies, sepsis and other systemic illnesses

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the total serum Bilirubin levelTimepoint: Day 0 <br/ ><br>Day 3 <br/ ><br>Day 5 <br/ ><br>Day 7
Secondary Outcome Measures
NameTimeMethod
changes in the extent of clinical icterus based on crammers criteriaTimepoint: Day 0 <br/ ><br>Day 3 <br/ ><br>Day 5 <br/ ><br>Day 7
© Copyright 2025. All Rights Reserved by MedPath